Journal of Contemporary Brachytherapy

Dosimetric impact of computed tomography slice thickness-induced applicator reconstruction uncertainties in three-dimensional brachytherapy for cervical cancer

Wei Huang 1
,
Haixia Cui 1
,
Dongshan Wei 1
,
Xiuquan Li 1
,
Qiong Wang 2
,
Qingfeng Jiang 1

  1. Department of Oncology, Laboratory of Immunity, Inflammation & Cancer, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

  2. Chongqing Engineering Research Center of Pharmaceutical Sciences, Chongqing Medical and Pharmaceutical College, Chongqing, China

J Contemp Brachytherapy 2026

DOI: https://doi.org/10.5114/jcb.2026.164179
Data publikacji online: 2026/08/19
Article files
Dosimetric impact of CT.pdf Dosimetric impact of CT - supplementary table.pdf
  1. Green JA, Kirwan JM, Tierney JF et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001; 358: 781-786.
  2. Abu-Rustum NR, Yashar CM, Arend R et al. NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024. J Natl Compr Canc Netw 2023; 21: 1224-1233.
  3. Yang T, Zhao T, Ji Z et al. The safety and efficacy of volumetric modulated Arc therapy combined with computer tomography-guided adaptive brachytherapy for locally advanced cervical cancer: a single institution experience. Radiat Oncol 2024; 19: 77.
  4. Pötter R, Tanderup K, Schmid MP et al. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol 2021; 22: 538-547.
  5. Grover S, Harkenrider MM, Cho LP et al. Image guided cervical brachytherapy: 2014 Survey of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys 2016; 94: 598-604.
  6. Taggar AS, Phan T, Traptow L et al. Cervical cancer brachytherapy in Canada: A focus on interstitial brachytherapy utilization. Brachytherapy 2017; 16: 161-166.
  7. Tan LT, Tanderup K, Kirisits C et al. Education and training for image-guided adaptive brachytherapy for cervix cancer-The (GEC)-ESTRO/EMBRACE perspective. Brachytherapy 2020; 19: 827-836.
  8. Derks K, Steenhuijsen JLG, van den Berg HA et al. Impact of brachytherapy technique (2D versus 3D) on outcome following radiotherapy of cervical cancer. J Contemp Brachytherapy 2018; 10: 17-25.
  9. Tanderup K, Fokdal LU, Sturdza A et al. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. Radiother Oncol 2016; 120: 441-446.
  10. Sturdza A, Pötter R, Fokdal LU et al. Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol 2016; 120: 428-433.
  11. Simpson DR, Scanderbeg DJ, Carmona R et al. Clinical out-comes of computed tomography-based volumetric brachytherapy planning for cervical cancer. Int J Radiat Oncol Biol Phys 2015; 93: 150-157.
  12. Cho LP, Manuel M, Catalano P et al. Outcomes with volume-based dose specification in CT-planned high-dose-rate brachytherapy for stage I-II cervical carcinoma: A 10-year institutional experience. Gynecol Oncol 2016; 143: 545-551.
  13. Chan WL, Cheng MH, Wu JT et al. Treatment outcomes of computer tomography-guided brachytherapy in cervical cancer in Hong Kong: A retrospective review. Cancers (Basel) 2022; 14: 3934.
  14. Uezono H, Tsujino K, Inoue Y et al. CT-based image-guided brachytherapy in uterine cervical cancer: Effect of tumor dose and volume on local control. Brachytherapy 2022; 21: 814-822.
  15. Hellebust TP, Kirisits C, Berger D et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol 2010; 96: 153-160.
  16. Hellebust TP, Tanderup K, Bergstrand ES et al. Reconstruction of a ring applicator using CT imaging: impact of the reconstruction method and applicator orientation. Phys Med Biol 2007; 52: 4893-4904.
  17. Jayarathna S, Hoang M, Badkul R et al. Dosimetric impact of applicator displacement on three-dimensional image-guided high-dose-rate brachytherapy treatments for cervical cancer. J Contemp Brachytherapy 2023; 15: 334-343.
  18. Tanderup K, Hellebust TP, Lang S et al. Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer. Radiother Oncol 2008; 89: 156-163.
  19. Kirisits C, Rivard MJ, Baltas D et al. Review of clinical brachytherapy uncertainties: analysis guidelines of GEC-ESTRO and the AAPM. Radiother Oncol 2014; 110: 199-212.
  20. Sargazi V, Naseri S, Gholamhosseinian H et al. Applicator reconstruction in cervical cancer brachytherapy: A systematic review of current methods, challenges, and AI-driven future directions. Brachytherapy 2026; 25: 262-274.
  21. Hu H, Yang Q, Li J et al. Deep learning applications in automatic segmentation and reconstruction in CT-based cervix brachytherapy. J Contemp Brachytherapy 2021; 13: 325-330.
  22. Zhang D, Yang Z, Jiang S et al. Automatic segmentation and applicator reconstruction for CT-based brachytherapy of cervical cancer using 3D convolutional neural networks. J Appl Clin Med Phys 2020; 21: 158-169.
  23. Deufel CL, Tian S, Yan BB et al. Automated applicator digitization for high-dose-rate cervix brachytherapy using image thresholding and density-based clustering. Brachytherapy 2020; 19: 111-118.
  24. Dise J, Liang X, Scheuermann J et al. Development and evaluation of an automatic interstitial catheter digitization tool for adaptive high-dose-rate brachytherapy. Brachytherapy 2015; 14: 619-625.
  25. Kim Y, Modrick JM, Pennington EC et al. Commissioning of a 3D image-based treatment planning system for high-dose-rate brachytherapy of cervical cancer. J Appl Clin Med Phys 2016; 17: 405-426.
  26. Monnin P, Sfameni N, Gianoli A et al. Optimal slice thickness for object detection with longitudinal partial volume effects in computed tomography. J Appl Clin Med Phys 2017; 18: 251-259.
  27. Abdulkareem NK, Hajee SI, Hassan FF et al. Investigating the slice thickness effect on noise and diagnostic content of single-source multi-slice computerized axial tomography. J Med Life 2023; 16: 862-867.
  28. Wang Y, Jian W, Zhu L et al. Attention-gated deep-learning-based automatic digitization of interstitial needles in high-dose-rate brachytherapy for cervical cancer. Adv Radiat Oncol 2024; 9: 101340.
  29. Rivard MJ, Coursey BM, DeWerd LA et al. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys 2004; 31: 633-674.
  30. Qing K, Yue NJ, Hathout L et al. The combined use of 2D scout and 3D axial CT images to accurately determine the catheter tips for high-dose-rate brachytherapy plans. J Appl Clin Med Phys 2021; 22: 273-278.
  31. Lakosi F, de Cuypere M, Viet Nguyen P et al. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience. Acta Oncol 2015; 54: 1558-1566.
  32. Schmid MP, Kirisits C, Nesvacil N et al. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis. Radiother Oncol 2011; 100: 468-472.
  33. Mazeron R, Fokdal LU, Kirchheiner K et al. Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study. Radiother Oncol 2016; 120: 412-419.
  34. Zhou YC, Zhao LN, Wang N et al. Late rectal toxicity determined by dose-volume parameters in computed tomography-based brachytherapy for locally advanced cervical cancer. Cancer Med 2016; 5: 434-441.
  35. Mahantshetty U, Poetter R, Beriwal S et al. IBS-GEC ESTRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer. Radiother Oncol 2021; 160: 273-284.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Indexed in
pubmed
Integrated with
integrated with publons
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications